Selective nigrosome vulnerability in Parkinson’s disease revealed by histology-anchored ultra-high-field quantitative MRI
Authors:
- Ruiyi LiRLRuiyi Li
- Evgeniya KirilinaEKEvgeniya Kirilina
- Pierre-Louis BazinPBPierre-Louis Bazin
- Kjersti Eline StigeKSKjersti Eline Stige
- Runa G. UnsgårdRURuna G. Unsgård
- Malte BrammerlohMBMalte Brammerloh
- Anne Louise KristoffersenAKAnne Louise Kristoffersen
- Erik Magnus BerntsenEBErik Magnus Berntsen
- Pål Erik GoaPGPål Erik Goa
- Philippe DamierPDPhilippe Damier
- Charalampos TzoulisCTCharalampos Tzoulis
Preprint
Abstract
Selective vulnerability is a hallmark of Parkinson’s disease (PD): post-mortem, dopamine-containing cell loss in the substantia nigra first and most severely affects calbindin-poor compartments termed nigrosomes. Testing this in vivo has been limited by circularity, as MRI studies have delineated nigrosomes from the same disease-related contrast they then measure. Here, we warp histology-derived, calbindin-validated probabilistic masks of nigrosomes 1-5 into a cohort-specific multimodal 7 Tesla quantitative MRI template, providing a degeneration-independent anatomical scaffold, in 28 patients with PD and 28 age- and sex-matched controls. In controls, nigrosomes differ from the surrounding nigral matrix in magnetic susceptibility and R1. PD shifts nigrosomal values upward relative to the matrix in susceptibility, R2*, and R1, concentrated in nigrosomes 1, 2, and 4, whereas whole-nigra analysis shows no group difference. Within the matrix, disease effects are largest caudally and emerge dorsally from the ventral tier, and susceptibility alterations in nigrosomes 1 and 4 track contralateral motor symptoms asymmetry. The multimodal pattern suggests that the detectable signal reflects predominantly secondary, iron-associated glial processes rather than neuronal loss itself. These findings recover the post-mortem spatial pattern of nigral vulnerability in vivo and establish a degeneration-independent framework for subregional nigral imaging in PD.Keywords
Funding Information
- EU Joint Programme - Neurodegenerative Disease Research (01ED2508)
- Central Norway Regional Health Authority
- Western Norway Regional Health Authority
- Centre Hospitalier Universitaire de Nantes
- Norwegian Parkinson's Association
This publication has 57 references indexed in Scilit:
- The Costs of Parkinson's Disease in Europe: Results of the Costs of Illness in Neurology InitiativeMovement Disorders, 2026
- 7 Tesla MRI with Quantitative Susceptibility Mapping: qualitative grading and quantitative focal measurements of the substantia nigra as a potential biomarker for Parkinson’s diseaseNeuroradiology, 2026
- Early‐stage Parkinson's disease: Abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin‐sensitive MRIHuman Brain Mapping, 2021
- Differential involvement of nigral subregions in idiopathic parkinson's diseaseHuman Brain Mapping, 2017
- Computationally Efficient Combination of Multi‐channel Phase Data From Multi‐echo Acquisitions (ASPIRE)Magnetic Resonance in Medicine, 2017
- ESNR 2017Neuroradiology, 2017
- MDS clinical diagnostic criteria for Parkinson's diseaseMovement Disorders, 2015
- High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's diseaseJournal of Magnetic Resonance Imaging, 2011
- Rapid B1+ mapping using a preconditioning RF pulse with TurboFLASH readoutMagnetic Resonance in Medicine, 2010
- Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?Movement Disorders, 2003